
LucenceINSIGHT® screens for the signal of up to 50 cancers in 1 blood test.


LucenceINSIGHT® screens for cancer with low false-positives.


A report will be ready 15-18 working days after sample is accepted by the lab.
No fasting is needed. Refrain from heavy meals 4 hours before. Blood draw is recommended 4 hours before dialysis.

LucenceINSIGHT® is recommended for patients who:
-
are aged 40+
-
have elevated risk of cancer (family history, diet, lifestyle).

This test is not recommended for patients who:
-
are pregnant.
-
are in cancer remission for < 3 years.
-
had surgery, an allogenic bone transplant or a blood transfusion < 2 weeks prior to sample collection.
Frequently Asked Questions

References
- Poh, J. et al. J. Clin. Oncol. 2024; 42(16): e15042.
- Cumulative risk of 43.1% false positives over 14 screening exams from other tumor marker screening methods including chest radiograph, flexible sigmoidoscopy, CA-125, and transvaginal ultrasonography for women, and chest radiograph, flexible sigmoidoscopy, PSA, and DRE for men. (Croswell, J. et al. Ann. Fam. Med. 2009; 7(3): 212–222.)
- Dorsheimer, L. et al. JAMA Cardiol. 2019; 4(1): 25-30.
- Libby, P. et al. JAMA Cardiol. 2019; 4(1): 5-6.
- Jaiswal S. et al. N. Engl. J. Med. 2014; 371(26): 2488–98.

©2025 Lucence Diagnostics Pte Ltd. All rights reserved. All logos and trademarks are the property of Lucence or their respective owners. The information on this site is intended for audiences in Singapore and Hong Kong only.